UNII 4ELV7Z65AP

STEARIC ACID

Unique Ingredient Identifier 4ELV7Z65AP is listed as a ingredient substance
RN57-11-4
EC200-313-4
NCITC68426
RXCUI1310551
PUBCHEM5281
MFC18H36O2
INCHI KEYQIQXTHQIDYTFRH-UHFFFAOYSA-N
SMILESCCCCCCCCCCCCCCCCCC(O)=O

Alternate Names

Dosage Forms

UNII 4ELV7Z65AP STEARIC ACID is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALTABLET5 MG
BUCCAL/SUBLINGUALTABLET6 MG
IMPLANTATIONPELLET0.2 MG
ORALCAPSULE52 MG
ORALCAPSULE, COATED, SOFT GELATIN3 MG
ORALCAPSULE, DELAYED ACTION3 MG
ORALCAPSULE, EXTENDED RELEASE3.23 MG
ORALCAPSULE, HARD GELATIN15 MG
ORALCAPSULE, SUSTAINED ACTION21 MG
ORALPOWDER, FOR SUSPENSION1203 MG/5ML
ORALSYRUP NA
ORALTABLET72 MG
ORALTABLET (IMMED./COMP. RELEASE), COATED5.3 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE15 MG
ORALTABLET, CHEWABLE10 MG
ORALTABLET, COATED42.4 MG
ORALTABLET, CONTROLLED RELEASE1.6 MG
ORALTABLET, DELAYED ACTION20 mg
ORALTABLET, DELAYED ACTION, ENTERIC COATED16 MG
ORALTABLET, DELAYED RELEASE20 mg
ORALTABLET, ENTERIC COATED PARTICLES5 MG
ORALTABLET, EXTENDED RELEASE180 MG
ORALTABLET, FILM COATED22 MG
ORALTABLET, ORALLY DISINTEGRATING10 MG
ORALTABLET, SUGAR COATED0.9 MG
ORALTABLET, SUSTAINED ACTION187.5 MG
ORALTABLET, SUSTAINED RELEASE, FILM COATED9 MG
SUBCUTANEOUSIMPLANT1.04 MG
SUBLINGUALTABLET5.05 MG
TOPICALCREAM, AUGMENTED3 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE16 %W/W
TOPICALEMULSION, AEROSOL FOAM8 %W/W
TOPICALEMULSION, CREAM22.5 %W/W
TOPICALEMULSION, CREAM5 %W/W
TOPICALLOTION2 %W/W
TOPICALOINTMENT15 %W/W
TOPICALSOLUTION NA
TOPICALSUSPENSION1.75 %W/W
VAGINALEMULSION, AEROSOL FOAM4 %
VAGINALEMULSION, CREAM14 %
VAGINALTABLET60 MG

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.